Related Research Articles
Tak Wah Mak, is a Canadian medical researcher, geneticist, oncologist, and biochemist. He first became widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology. In 1995, Mak published a landmark paper on the discovery of the function of the immune checkpoint protein CTLA-4, thus opening the path for immunotherapy/checkpoint inhibitors as a means of cancer treatment. Mak is also the founder of Agios Pharmaceuticals, whose lead compound, IDHIFA®, was approved by the FDA for acute myeloid leukemia in August 2017, becoming the first drug specifically targeting cancer metabolism to be used for cancer treatment. He has worked in a variety of areas including biochemistry, immunology, and cancer genetics.
Pamela Jane Bjorkman NAS, AAAS is an American biochemist and molecular biologist. She is the David Baltimore Professor of Biology and Biological Engineering at the California Institute of Technology (Caltech). Her research centers on the study of the three-dimensional structures of proteins related to Class I MHC, or Major Histocompatibility Complex, proteins of the immune system, and proteins involved in the immune responses to viruses. Bjorkman's goal is to improve current therapeutic applications. Bjorkman is most well known as a pioneer in the field of structural biology.
Andrew Zachary Fire is an American biologist and professor of pathology and of genetics at the Stanford University School of Medicine. He was awarded the 2006 Nobel Prize in Physiology or Medicine, along with Craig C. Mello, for the discovery of RNA interference (RNAi). This research was conducted at the Carnegie Institution of Washington and published in 1998.
Leonard Arthur "Len" Herzenberg was an immunologist, geneticist and professor at Stanford University. His contributions to the development of cell biology made it possible to sort viable cells by their specific properties.
Klaus Rajewsky is a German immunologist, renowned for his work on B cells.
Philippa "Pippa" Marrack, FRS is an English immunologist and academic, based in the United States, best known for her research and discoveries pertaining to T cells. Marrack is the Ida and Cecil Green Professor and chair of the Department of Biomedical Research at National Jewish Health and a distinguished professor of immunology and microbiology at the University of Colorado Denver.
Harald von Boehmer was a German-Swiss immunologist and author best known for his work on T cells.
Timothy "Tim" A. Springer is an immunologist and the Latham Family Professor at Harvard Medical School. He is also a professor at the Department of Biological Chemistry and Molecular Pharmacology and of the Division of Medical Sciences, and a Senior Investigator at the Research Program in Cellular and Molecular Medicine of the Boston Children's Hospital. Springer is best known for discovering the first integrins, LFA-1, and intercellular adhesion molecules (ICAMs), and for elucidating how these cell adhesion molecules function in the immune system. In recent years, Springer's research interest has expanded to malaria, transforming growth factor beta (TGF-β) signaling, and von Willebrand factor.
Sir James Learmonth "Jim" Gowans was a British physician and immunologist. In 1945, while studying medicine at King's College Hospital, he assisted at the liberated Bergen-Belsen concentration camp as a voluntary medical student.
Christopher Carl Goodnow is an immunology researcher and the current executive director of the Garvan Institute of Medical Research. He holds the Bill and Patricia Ritchie Foundation Chair and is a Conjoint Professor in the faculty of medicine at UNSW Sydney. He holds dual Australian and US citizenship.
James Patrick Allison is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center in Houston, Texas. Allison is Regental Professor and Founding-Director of James P. Allison Institute at the MD Anderson Cancer Center.
Harvey Cantor is an American immunologist known for his studies of the development and immunological function of T lymphocytes. Cantor is currently the Baruj Benacerraf Professor of Immunology and Microbiology at the Harvard Medical School.
The Szent-Györgyi Prize for Progress in Cancer Research, established by National Foundation for Cancer Research (NFCR) and named in honor of Albert Szent-Györgyi, Nobel laureate and co-founder of NFCR, has been awarded annually since 2006 to outstanding researchers whose scientific achievements have expanded the understanding of cancer and whose vision has moved cancer research in new directions. The Szent-Györgyi Prize honors researchers whose discoveries have made possible new approaches to preventing, diagnosing and/or treating cancer. The Prize recipient is honored at a formal dinner and award ceremony and receives a $25,000 cash prize. In addition, the recipient leads the next "Szent-Györgyi Prize Committee" as honorary chairman.
Max Dale Cooper, is an American immunologist and a professor at the Department of Pathology and Laboratory Medicine and the Emory Vaccine Center of Emory University School of Medicine. He is known for characterizing T cells and B cells.
The Cancer Research Institute (CRI) is a US non-profit organization funding cancer research and based in New York City. They were founded in 1953 to develop immunologically-based treatments for cancer, and despite their name are a funding body for research rather than a research institute themselves, working with other institutes and organizations. It was founded by Helen Coley Nauts and Oliver R. Grace with a $2,000 grant from Nelson Rockefeller. CRI was created in honor of Nauts' father, William Coley (1862–1936), an American orthopedic surgeon and a pioneer of cancer immunotherapy. Grounded in Dr. Coley’s pioneering work, the Cancer Research Institute focuses on immunological treatments for cancer, both as a single treatment approach as well as a complement and enhancer to traditional treatments, such as chemotherapy and surgery.
Shimon Sakaguchi is an immunologist and a Distinguished Professor of Osaka University. He is best known for the discovery of regulatory T cells and describing their role in the immune system. This discovery is used in the treatment of cancer and autoimmune diseases.
Andrea Ablasser is a German immunologist, who works as a full professor of Life Sciences at the École Polytechnique Fédérale de Lausanne. Her research has focused on how the innate immune system is able to recognise virus-infected cells and pathogens.
Mark Morris Davis is an American immunologist. He is the director of and Avery Family Professor of Immunology at the Institute for Immunity, Transplantation and Infection at Stanford University.
Michel C. Nussenzweig is a professor and head of the Laboratory of Molecular Immunology at The Rockefeller University and a Howard Hughes Medical Institute investigator. He is a member of both the US National Academy of Medicine and the US National Academy of Sciences.
Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.
References
- 1 2 "Frederick W. Alt, PhD - DF/HCC". Dana-Farber / Harvard Cancer Center. Archived from the original on October 8, 2023. Retrieved January 13, 2025.
- ↑ "How new loops in DNA packaging help us make diverse antibodies". phys.org. Retrieved November 14, 2019.
- 1 2 "Pioneering geneticist Frederick Alt '71 wins 44th Rosenstiel Award". BrandeisNOW. Retrieved November 14, 2019.
- ↑ "Alt Laboratory". www.childrenshospital.org. Retrieved December 29, 2022.
- ↑ "Children's Hospital bio". Archived from the original on January 20, 2018. Retrieved September 10, 2011.
- ↑ "J. Kenji López-Alt: Seattle's Famous Japanese American Cooking Star". The North American Post. September 23, 2022. Archived from the original on October 6, 2022. Retrieved December 9, 2022.
- ↑ Robertson, Blair Anthony (2015). "Science becomes delicious in 'The Food Lab'". The Sacramento Bee. Archived from the original on December 16, 2015. Retrieved November 13, 2019.
His father, Frederick Alt, is a professor at Harvard Medical School
- ↑ "Laureates". Novartis Prizes for Immunology. August 29, 2018. Archived from the original on August 29, 2018. Retrieved November 14, 2019.
- ↑ "CRI Announces Winner of 2009 Frederick Alt Award for New Discoveries in Immunology". Cancer Research Institute. October 6, 2009. Retrieved November 14, 2019.
- ↑ Scully, Peter; Zhao, Jie; Ba, Sujuan (February 3, 2016). "Frederick W. Alt received the 2015 Szent-Györgi Prize for Progress in Cancer Research". Chinese Journal of Cancer. 35: 17. doi: 10.1186/s40880-015-0075-x . ISSN 1000-467X. PMC 4741029 . PMID 26843073.
- ↑ "AAI-BioLegend Herzenberg Award". The American Association of Immunologists, Inc. (AAI).
- ↑ "AAI Career Awards". Immunology 2019. Retrieved November 14, 2019.
- ↑ Paul Ehrlich and Ludwig Darmstaedter Prize 2023
